['hypoglycemia', 'diabetes mellitus, type 1']
['nasal glucagon', 'intramuscular glucagon']

        Inclusion Criteria:

          -  Diagnosis of Type 1 Diabetes Mellitus (T1DM) for at least 2 years and receiving daily
             insulin since the time of diagnosis

        Exclusion Criteria:

          -  Have a history of hypersensitivity to glucagon or any related products or severe
             hypersensitivity reactions (such as angioedema) to any drugs

          -  Have a history of pheochromocytoma (that is, adrenal gland tumor) or insulinoma

          -  Occurrence of an episode of severe hypoglycemia (defined as requiring the assistance
             of another person in the 1 month prior to enrolling in the study)

          -  Have a history of epilepsy or seizure disorder

          -  Are women who are pregnant or lactating

          -  Have, except for the current regimen of insulin therapy and concomitant medication,
             regular use of or intended use of any over-the-counter or prescription medications or
             nutritional supplements that treat hyperglycemia or insulin resistance or that promote
             weight loss within 14 days before dosing

          -  Daily use of systemic beta-blocker, indomethacin, warfarin or anticholinergic drugs

          -  Require daily insulin treatment greater than (>)1.5 unit/kilograms (U/kg)/body weight
      